You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 8, August 27, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Topic Collections
 •Rehabilitation Medicine
 •Osteoarthritis
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic

Methodological Differences in Clinical Trials Evaluating Nonpharmacological and Pharmacological Treatments of Hip and Knee Osteoarthritis

Isabelle Boutron, MD; Florence Tubach, MD; Bruno Giraudeau, PhD; Philippe Ravaud, MD, PhD

JAMA. 2003;290:1062-1070.

Context  Randomized controlled trials have been developed essentially in the context of pharmacological treatments (ie, oral drugs; intra-articular injection; and topical, intramuscular, and intravenous treatments), but assessment of the effectiveness of nonpharmacological treatments (ie, surgery, arthroscopy, joint lavage, rehabilitation, acupuncture, and education) presents specific issues.

Objectives  To compare the quality of articles of nonpharmacological and pharmacological treatments of hip and knee osteoarthritis and to identify specific methodological issues related to assessment of nonpharmacological treatments.

Design and Setting  We searched MEDLINE and the Cochrane Central Register of Controlled Trials for articles of randomized controlled trials published between January 1, 1992, and February 28, 2002, in 28 general medical and specialty journals with high impact factors and assessing nonpharmacological and pharmacological treatments in patients with hip or knee osteoarthritis.

Main Outcome Measures  The quality of the methods reported in the selected articles was assessed by 2 independent reviewers using the Jadad scale, the Delphi list, and guidelines found in the Users' Guides to the Medical Literature. Investigators also used a checklist of items developed by the authors to analyze study characteristics.

Results  A total of 110 articles were included in the analysis; 50 (45.5%) assessed nonpharmacological treatments and 60 (54.5%) assessed pharmacological treatments. Reports of nonpharmacological treatments had a lower global quality score than did reports of pharmacological treatments as measured by the Jadad scale (mean [SD] score, 1.4 [1.3] vs 3.0 [1.3]) and the Delphi list (mean [SD] score, 5.2 [1.5] vs 7.5 [1.1]). Lack of reporting adequate random sequence generation and intention-to-treat analyses were found in both nonpharmacological and pharmacological articles. Nonpharmacological treatments were less often compared with a placebo than were pharmacological treatments (28.0% of articles vs 71.7%). Compared with pharmacological articles, nonpharmacological articles less often described blinding of patients (26.0% vs 96.7%), care providers (6.0% vs 81.7%), and outcome assessors (68.0% vs 98.3%). Care providers' skill levels could influence treatment effect in 84.0% of nonpharmacological articles vs 23.3% of pharmacological articles.

Conclusions  In this analysis of reports of hip and knee osteoarthritis therapy, nonpharmacological articles scored lower than pharmacological articles in terms of quality. Assessments of nonpharmacological treatments must take into consideration additional methodological issues.


Author Affiliations: Département d'Epidémiologie, Biostatistique et Recherche Clinique, Groupe Hospitalier Bichat–Claude Bernard (Assistance Publique des Hôpitaux de Paris), Faculté Xavier Bichat, Université Paris VII (Drs Boutron, Tubach, and Ravaud), and INSERM EMI 0357 (Drs Boutron, Tubach, and Ravaud), Paris, France; and INSERM CIC 202, Tours, France (Dr Giraudeau).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
Boutron et al.
ANN INTERN MED 2008;148:295-309.
ABSTRACT | FULL TEXT  

Methods and Processes of the CONSORT Group: Example of an Extension for Trials Assessing Nonpharmacologic Treatments
Boutron et al.
ANN INTERN MED 2008;148:W-60-W-66.
ABSTRACT | FULL TEXT  

Scales to Assess the Quality of Randomized Controlled Trials: A Systematic Review
Olivo et al.
ptjournal 2008;88:156-175.
ABSTRACT | FULL TEXT  

Acupuncture: What Underlies Needle Administration?
Liu
Evid Based Complement Alternat Med 2008;0:nen002v1-nen002.
ABSTRACT | FULL TEXT  

Effectiveness of Nonpharmacological and Nonsurgical Interventions for Patients With Rheumatoid Arthritis: An Overview of Systematic Reviews
Christie et al.
ptjournal 2007;87:1697-1715.
ABSTRACT | FULL TEXT  

Effectiveness of Nonpharmacological and Nonsurgical Interventions for Hip Osteoarthritis: An Umbrella Review of High-Quality Systematic Reviews
Moe et al.
ptjournal 2007;87:1716-1727.
ABSTRACT | FULL TEXT  

The Quality of Reporting of Orthopaedic Randomized Trials with Use of a Checklist for Nonpharmacological Therapies
Chan and Bhandari
JBJS 2007;89:1970-1978.
ABSTRACT | FULL TEXT  

Non-drug care for RA is the era of evidence-based practice approaching?
Vliet Vlieland
Rheumatology (Oxford) 2007;46:1397-1404.
ABSTRACT | FULL TEXT  

The design and assessment of prospective randomised, controlled trials in orthopaedic surgery
Boutron et al.
J Bone Joint Surg Br 2007;89-B:858-863.
ABSTRACT | FULL TEXT  

Perceptions and Competence in Evidence-Based Medicine: Are Surgeons Getting Better? A Questionnaire Survey of Members of the Dutch Orthopaedic Association
Poolman et al.
JBJS 2007;89:206-215.
ABSTRACT | FULL TEXT  

Lunate Chondromalacia: Evaluation of Routine MRI Sequences
Bordalo-Rodrigues et al.
Am. J. Roentgenol. 2005;184:1464-1469.
ABSTRACT | FULL TEXT  

Inappropriateness of randomised trials for complex phenomena: Single trial is never enough evidence to base decisions on
Boutron et al.
BMJ 2005;330:94-94.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.